Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.
Trials
; 23(1): 148, 2022 Feb 14.
Article
in En
| MEDLINE
| ID: mdl-35164840
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2022
Document type:
Article
Affiliation country:
Mexico
Country of publication:
United kingdom